From CTV News:
An experimental treatment for multiple sclerosis that uses an antibiotic along with a common MS medication may slow the progress of the disease, finds a preliminary study set to appear in the February 2008 issue of Archives of Neurology.
The treatment involved combining doxycycline and interferon, a commonly prescribed MS medication that boosts the immune system and fights viruses.
Many patients with relapsing-remitting MS -- the most common form of the disease -- take interferon, but many still experience relapses and may continue to develop new areas of damaged brain tissue called lesions, one of the key markers of MS. ...more
Monday, December 10, 2007
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment